Intech Investment Management LLC Cuts Position in HCA Healthcare, Inc. $HCA

Intech Investment Management LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 24.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 150,783 shares of the company’s stock after selling 49,873 shares during the period. HCA Healthcare comprises about 0.5% of Intech Investment Management LLC’s holdings, making the stock its 27th largest holding. Intech Investment Management LLC owned approximately 0.06% of HCA Healthcare worth $57,765,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Park Place Capital Corp lifted its stake in shares of HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares during the period. Harrell Investment Partners LLC increased its stake in shares of HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after buying an additional 1,158 shares during the period. Cherokee Insurance Co bought a new stake in HCA Healthcare in the 2nd quarter worth $3,869,000. Finally, Simon Quick Advisors LLC raised its stake in shares of HCA Healthcare by 616.9% during the second quarter. Simon Quick Advisors LLC now owns 7,147 shares of the company’s stock valued at $2,738,000 after acquiring an additional 6,150 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.2%

HCA Healthcare stock opened at $472.40 on Friday. The business’s fifty day simple moving average is $433.56 and its two-hundred day simple moving average is $396.06. The company has a market capitalization of $107.80 billion, a price-to-earnings ratio of 18.26, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $480.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the prior year, the firm posted $4.90 EPS. HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on HCA shares. Wells Fargo & Company upped their price target on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a research report on Thursday. Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Robert W. Baird increased their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Finally, Barclays raised their target price on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $474.53.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.